EUROPE SEPSIS DIAGNOSTICS MARKET 2021-2028

Lifesciences | Medical Devices & Consumables

EUROPE SEPSIS DIAGNOSTICS MARKET 2021-2028

Market by Technology, Diagnostic Method, Product, Pathogen, Testing Type, and Country | Forecast 2021-2028

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

As per Triton’s report, the sepsis diagnostics market in Europe is predicted to observe growth at a CAGR of 8.36% during the forecasting years of 2021-2028.


Report scope can be customized per your requirements. Request For Customization

The countries studied in this market comprise:

•        The United Kingdom

•        Spain

•        Germany

•        Italy

•        France

•        Russia

•        Rest of Europe

The market’s robust growth in the region can be attributed to the rising prevalence of sepsis. Also, the high mortality rate has triggered the need for early diagnosis of sepsis, which is likely to influence the demand for sepsis diagnostics. Hence, these factors drive the growth of the sepsis diagnostics market across Europe.

In Germany, as per multiple surveys, there has been a gradual decline in the mortality rate associated with sepsis. This is primarily owing to the better healthcare services provided across the nation. Additionally, people are becoming more aware of the disease, and healthcare professionals are becoming highly skilled. Such developments have made the diagnosis of the disease easier and efficient. Along with this, the country is known for its well-developed R&D infrastructure, gaining the attention of several international companies. Hence, as stated above, these factors support the expansion of the sepsis diagnostics market in Germany.

On the other hand, in France, the market is majorly driven due to the surge in sepsis cases, along with the increase in the number of diagnostic companies setting operations in the country. As per the Pasteur Institute estimates, a non-profit dedicated to studying diseases and vaccines, the sepsis cases are likely to double in the next 50 years due to the rise in the geriatric population. This creates a severe burden on the healthcare industry, increasing the demand for sepsis diagnosis and treatment, further supplementing the growth of France’s sepsis diagnostics market.

Biomerieux SA offers solutions and products related to the diagnosis and management of infectious diseases, cardiovascular conditions, and targeted cancers. The company also provides solutions for enumerating microbial flora, monitoring air and surface quality, and sterility testing for cosmetics and other products. Its healthcare segment serves medical clinics, pharmaceuticals, dental practitioners, and the food manufacturing industry. Founded in 1963, the company has headquarters in France. 

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1. EUROPE SEPSIS DIAGNOSTICS MARKET - SUMMARY

2. INDUSTRY OUTLOOK

2.1. IMPACT OF COVID-19 ON SEPSIS DIAGNOSTICS MARKET

2.2. KEY INSIGHTS

2.3. PORTER’S FIVE FORCES MODEL

2.3.1. THREAT OF NEW ENTRANTS

2.3.2. THREAT OF SUBSTITUTE PRODUCTS

2.3.3. BARGAINING POWER OF BUYERS

2.3.4. BARGAINING POWER OF SUPPLIERS

2.3.5. COMPETITIVE RIVALRY

2.4. MARKET ATTRACTIVENESS INDEX

2.5. VENDOR SCORECARD

2.6. KEY MARKET STRATEGIES

2.6.1. CONTRACTS AND PARTNERSHIP

2.6.2. BUSINESS EXPANSION AND DIVESTITURES

2.6.3. ACQUISITIONS & MERGERS

2.6.4. NEW PRODUCT LAUNCHES

2.7. MARKET DRIVERS

2.7.1. RISE IN HOSPITAL-ACQUIRED INFECTIONS AMONG PATIENTS

2.7.2. INCREASED PREVALENCE OF SEPSIS

2.8. MARKET RESTRAINTS

2.8.1. HIGH COST ASSOCIATED WITH THE INSTRUMENT

2.8.2. REIMBURSEMENT ISSUES

2.9. MARKET OPPORTUNITIES

2.9.1. RISING GOVERNMENT INITIATIVES FOR RESEARCH ACTIVITIES RELATED TO SEPSIS

3. EUROPE SEPSIS DIAGNOSTICS MARKET - BY TECHNOLOGY

3.1. MICROBIOLOGY

3.2. IMMUNOASSAY

3.3. MOLECULAR DIAGNOSTICS

3.4. OTHER TECHNOLOGIES

4. EUROPE SEPSIS DIAGNOSTICS MARKET - BY DIAGNOSTIC METHOD

4.1. CONVENTIONAL DIAGNOSTICS

4.2. AUTOMATED DIAGNOSTICS

5. EUROPE SEPSIS DIAGNOSTICS MARKET - BY PRODUCT

5.1. BLOOD CULTURE MEDIA

5.2. ASSAY KITS & REAGENTS

5.3. INSTRUMENTS

6. EUROPE SEPSIS DIAGNOSTICS MARKET - BY PATHOGEN

6.1. GRAM - POSITIVE AND GRAM - NEGATIVE BACTERIAL SEPSIS

6.2. FUNGAL SEPSIS

6.3. OTHER PATHOGENS

7. EUROPE SEPSIS DIAGNOSTICS MARKET - BY TESTING TYPE

7.1. LABORATORY TESTING

7.2. POINT-OF-CARE TESTING

8. EUROPE SEPSIS DIAGNOSTICS MARKET – COUNTRY OUTLOOK

8.1. COUNTRY ANALYSIS

8.1.1. GERMANY

8.1.2. FRANCE

8.1.3. UNITED KINGDOM

8.1.4. ITALY

8.1.5. RUSSIA

8.1.6. SPAIN

8.1.7. REST OF EUROPE

9. COMPETITIVE LANDSCAPE

9.1. ABBOTT LABORATORIES

9.2. BECTON DICKINSON AND COMPANY (CR BARD)

9.3. BIOMERIEUX SA

9.4. BRUKER CORPORATION

9.5. CYTOSORBENTS

9.6. DANAHER CORPORATION

9.7. EKF DIAGNOSTICS

9.8. F. HOFFMANN-LA ROCHE

9.9. IMMUNEXPRESS INC

9.10. LUMINEX CORPORATION

9.11. RESPONSE BIOMEDICAL CORPORATION

9.12. T2 BIOSYSTEMS INC

9.13. THERMO FISHER SCIENTIFIC INC

10. RESEARCH METHODOLOGY & SCOPE

10.1. RESEARCH SCOPE & DELIVERABLES

10.1.1. OBJECTIVES OF STUDY

10.1.2. SCOPE OF STUDY

10.2. SOURCES OF DATA

10.2.1. PRIMARY DATA SOURCES

10.2.2. SECONDARY DATA SOURCES

10.3. RESEARCH METHODOLOGY

10.3.1. EVALUATION OF PROPOSED MARKET

10.3.2. IDENTIFICATION OF DATA SOURCES

10.3.3. ASSESSMENT OF MARKET DETERMINANTS

10.3.4. DATA COLLECTION

10.3.5. DATA VALIDATION & ANALYSIS

List of Tables

TABLE 1:       EUROPE SEPSIS DIAGNOSTICS MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)

TABLE 2:       MARKET ATTRACTIVENESS INDEX

TABLE 3:       VENDOR SCORECARD

TABLE 4:       LIST OF CONTRACTS & PARTNERSHIPS

TABLE 5:       LIST OF BUSINESS EXPANSIONS & DIVESTITURES

TABLE 6:       LIST OF ACQUISITIONS & MERGERS

TABLE 7:       LIST OF NEW PRODUCT LAUNCHES

TABLE 8:       EUROPE SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2028 (IN $ MILLION)

TABLE 9:       EUROPE SEPSIS DIAGNOSTICS MARKET, BY DIAGNOSTIC METHOD, 2021-2028 (IN $ MILLION)

TABLE 10:     EUROPE SEPSIS DIAGNOSTICS MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)

TABLE 11:     EUROPE SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN, 2021-2028 (IN $ MILLION)

TABLE 12:     GRAM-NEGATIVE BACTERIA CAUSING SEPSIS

TABLE 13:     GRAM-POSITIVE BACTERIA CAUSING SEPSIS

TABLE 14:     EUROPE SEPSIS DIAGNOSTICS MARKET, BY TESTING TYPE, 2021-2028 (IN $ MILLION)

TABLE 15:     EUROPE SEPSIS DIAGNOSTICS MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)

List of Figures

FIGURE 1:     EUROPE SEPSIS DIAGNOSTICS MARKET 2021-2028 (IN $ MILLION)

FIGURE 2:     EUROPE SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020 & 2028 (IN %)

FIGURE 3:     EUROPE SEPSIS DIAGNOSTICS MARKET, BY MICROBIOLOGY, 2021-2028 (IN $ MILLION)

FIGURE 4:     EUROPE SEPSIS DIAGNOSTICS MARKET, BY IMMUNOASSAY, 2021-2028 (IN $ MILLION)

FIGURE 5:     EUROPE SEPSIS DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2021-2028 (IN $ MILLION)

FIGURE 6:     EUROPE SEPSIS DIAGNOSTICS MARKET, BY OTHER TECHNOLOGIES, 2021-2028 (IN $ MILLION)

FIGURE 7:     EUROPE SEPSIS DIAGNOSTICS MARKET, BY DIAGNOSTIC METHOD, 2020 & 2028 (IN %)

FIGURE 8:     EUROPE SEPSIS DIAGNOSTICS MARKET, BY CONVENTIONAL DIAGNOSTICS, 2021-2028 (IN $ MILLION)

FIGURE 9:     EUROPE SEPSIS DIAGNOSTICS MARKET, BY AUTOMATED DIAGNOSTICS, 2021-2028 (IN $ MILLION)

FIGURE 10:  EUROPE SEPSIS DIAGNOSTICS MARKET, BY PRODUCT, 2020 & 2028 (IN %)

FIGURE 11:  EUROPE SEPSIS DIAGNOSTICS MARKET, BY BLOOD CULTURE MEDIA, 2021-2028 (IN $ MILLION)

FIGURE 12:  EUROPE SEPSIS DIAGNOSTICS MARKET, BY ASSAY KITS & REAGENTS, 2021-2028 (IN $ MILLION)

FIGURE 13:  EUROPE SEPSIS DIAGNOSTICS MARKET, BY INSTRUMENTS, 2021-2028 (IN $ MILLION)

FIGURE 14:  EUROPE SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN, 2020 & 2028 (IN %)

FIGURE 15:  EUROPE SEPSIS DIAGNOSTICS MARKET, BY GRAM - POSITIVE AND GRAM - NEGATIVE BACTERIAL SEPSIS, 2021-2028 (IN $ MILLION)

FIGURE 16:  EUROPE SEPSIS DIAGNOSTICS MARKET, BY FUNGAL SEPSIS, 2021-2028 (IN $ MILLION)

FIGURE 17:  EUROPE SEPSIS DIAGNOSTICS MARKET, BY OTHER PATHOGENS, 2021-2028 (IN $ MILLION)

FIGURE 18:  EUROPE SEPSIS DIAGNOSTICS MARKET, BY TESTING TYPE, 2020 & 2028 (IN %)

FIGURE 19:  EUROPE SEPSIS DIAGNOSTICS MARKET, BY LABORATORY TESTING, 2021-2028 (IN $ MILLION)

FIGURE 20:  EUROPE SEPSIS DIAGNOSTICS MARKET, BY POINT-OF-CARE TESTING, 2021-2028 (IN $ MILLION)

FIGURE 21:  EUROPE SEPSIS DIAGNOSTICS MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)

FIGURE 22:  GERMANY SEPSIS DIAGNOSTICS MARKET 2021-2028 (IN $ MILLION)

FIGURE 23:  FRANCE SEPSIS DIAGNOSTICS MARKET 2021-2028 (IN $ MILLION)

FIGURE 24:  UNITED KINGDOM SEPSIS DIAGNOSTICS MARKET 2021-2028 (IN $ MILLION)

FIGURE 25:  ITALY SEPSIS DIAGNOSTICS MARKET 2021-2028 (IN $ MILLION)

FIGURE 26:  RUSSIA SEPSIS DIAGNOSTICS MARKET 2021-2028 (IN $ MILLION)

FIGURE 27:  SPAIN SEPSIS DIAGNOSTICS MARKET 2021-2028 (IN $ MILLION)

FIGURE 28:  REST OF EUROPE SEPSIS DIAGNOSTICS MARKET 2021-2028 (IN $ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;